No Detail Found!

Glucose lowering effect of visfatin in obese and insulin dependent diabetes mellitus.

Author(s)
Raeesa Naz Department of Physiology, Army Medical College, Rawalpindi, Pakistan
Waqas Hameed Department of Physiology, Army Medical College, Rawalpindi, Pakistan
Muhammad Mazhar Hussain Department of Physiology, Army Medical College, Rawalpindi, Pakistan
Muhammad Aslam Shifa College of Medicine, Islamabad, Pakistan
Abstract
Background: Human obesity-related diabetes and the accompanying metabolic disorders have been specifically linked to increased visceral adipose tissue mass. Visfatin (pre-B-cell colony enhancing factor, PBEF) is a novel adipokine that appears to be preferentially produced by visceral adipose tissue that has insulin-mimetic actions. This study investigated if visfatin administration decreases blood glucose in both obese and insulin dependent diabetic mice. Methods: One hundred and twenty balb/C strain albino mice were divided into 4 groups. Animals in Group I and Group II were made obese by feeding high fat/high carbohydrate diet whereas Group III and Group IV were made insulin dependent diabetic by injecting streptozotocin. Group I and Group III served as controls whereas Group II and Group IV were administered visfatin injection intravenously as a single bolus dose. Blood samples were collected to measure the blood glucose and visfatin levels. Results: Visfatin levels were found increased in obese mice, while administration of recombinant-histidine soluble (mice) visfatin significantly decreased the blood glucose level in obese and insulin dependent diabetic mice (p
Publication Details
Page(s) 4-7
DOI DOI not available
Published Journal: Pakistan Journal of Physiology, Volume: 7, Issue: 1, Year: 2011

Request the full text from PASTIC

0

Citations

0

Downloads

75

Views